{"id":410394,"date":"2021-01-07T08:38:41","date_gmt":"2021-01-07T13:38:41","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=410394"},"modified":"2021-01-07T08:38:41","modified_gmt":"2021-01-07T13:38:41","slug":"infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\/","title":{"rendered":"Infinity Pharmaceuticals to Participate in Three Investor Conferences This Month"},"content":{"rendered":"

<\/p>\n

Infinity Pharmaceuticals to Participate in Three Investor Conferences This Month<\/b><\/p>\n

CAMBRIDGE, Mass.–(BUSINESS WIRE<\/a>)–Infinity Pharmaceuticals, Inc.<\/a> (NASDAQ: INFI) today announced that CEO Adelene Perkins is scheduled to present virtually at three investor conferences this month. The Infinity leadership team also will be available for one-on-one meetings during the investor conferences on January 7-8 and 11-14, 2021.\n<\/p>\n

\nDetails for all three investor conferences are as follows:\n<\/p>\n

39th Annual J.P. Morgan Healthcare Conference – Corporate Presentation<\/b><\/p>\n\n\n\n\n
\n

\nDate:\n<\/p>\n<\/td>\n

\n\n

\nJanuary 14, 2021\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nTime:\n<\/p>\n<\/td>\n

\n\n

\n2:00 p.m. ET\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nWebcast:\n<\/p>\n<\/td>\n

\n\n

\nAudio-only Link to Webcast Here<\/a><\/p>\n<\/td>\n<\/tr>\n<\/table>\n

2021 LifeSci Advisors – Corporate Access Event <\/b><\/p>\n\n\n\n
\n

\nDate:\n<\/p>\n<\/td>\n

\n\n

\nJanuary 7-13, 2021\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nTime:\n<\/p>\n<\/td>\n

\n\n

\nManagement available for 1×1 meetings\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

H.C. Wainwright BioConnect 2021 Conference – Corporate Presentation <\/b><\/p>\n\n\n
\n

\nDate:\n<\/p>\n<\/td>\n

\n\n

\nJanuary 11-14, 2021\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\nThe session time is on-demand, beginning Monday January 11 starting 6:00 a.m. ET.\n<\/p>\n

\nTo register<\/a> and view the presentation, please click here<\/a>.\n<\/p>\n

\nA replay for all conferences will be available on the Events and Presentations<\/a> section investor section of the Infinity Pharmaceuticals website https:\/\/investors.infi.com\/events-and-presentations\/upcoming-events<\/a> following the conference.\n<\/p>\n

About Infinity and Eganelisib <\/b><\/p>\n

\nInfinity is an innovative biopharmaceutical company dedicated to advancing novel medicines for people with cancer. Infinity is advancing eganelisib, a first-in-class, oral immuno-oncology development candidate that selectively inhibits PI3K-gamma, in multiple clinical studies. MARIO-275 is a global, randomized, placebo-controlled combination study of eganelisib combined with Opdivo\u00ae<\/sup> in I\/O na\u00efve urothelial cancer. MARIO-3 is the first eganelisib combination study in front-line advanced cancer patients and is evaluating eganelisib in combination with Tecentriq\u00ae<\/sup> and Abraxane\u00ae<\/sup> in front-line TNBC and in combination with Tecentriq and Avastin\u00ae<\/sup> in front-line RCC. In collaboration with Arcus Biosciences, Infinity is evaluating a checkpoint inhibitor-free, novel combination regimen of eganelisib plus etrumadenant (dual adenosine receptor antagonist) plus Doxil\u00ae<\/sup> in advanced TNBC patients. With these studies Infinity is evaluating eganelisib in the anti-PD-1 refractory, I\/O-na\u00efve, and front-line settings. For more information on Infinity, please refer to Infinity’s website at www.infi.com<\/a>.\n<\/p>\n

\nOpdivo\u00ae<\/sup> is a registered trademark of Bristol Myers Squibb.\n<\/p>\n

\nTecentriq\u00ae<\/sup> is a registered trademark of Genentech, Inc.\n<\/p>\n

\nAbraxane\u00ae<\/sup> is a registered trademark of Abraxis BioScience, LLC.\n<\/p>\n

\nAvastin\u00ae<\/sup> is a registered trademark of Genentech, Inc.\n<\/p>\n

\nDoxil\u00ae<\/sup> is a registered trademark of Baxter Healthcare Corporation.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210107005217\/en\/<\/a><\/span><\/p>\n

\nAshley Robinson
\n
LifeSci Advisors, LLC
\n
617-775-5956\n<\/p>\n

KEYWORDS:<\/b> Massachusetts United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Biotechnology Pharmaceutical Health<\/p>\n

MEDIA:<\/b><\/p>\n\n","protected":false},"excerpt":{"rendered":"

Infinity Pharmaceuticals to Participate in Three Investor Conferences This Month CAMBRIDGE, Mass.–(BUSINESS WIRE)–Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that CEO Adelene Perkins is scheduled to present virtually at three investor conferences this month. The Infinity leadership team also will be available for one-on-one meetings during the investor conferences on January 7-8 and 11-14, 2021. Details for all three investor conferences are as follows: 39th Annual J.P. Morgan Healthcare Conference – Corporate Presentation Date: January 14, 2021 Time: 2:00 p.m. ET Webcast: Audio-only Link to Webcast Here 2021 LifeSci Advisors – Corporate Access Event Date: January 7-13, 2021 Time: Management available for 1×1 meetings H.C. Wainwright BioConnect 2021 Conference – Corporate Presentation Date: January 11-14, 2021 The session time is … <\/p>\n

Continue reading “Infinity Pharmaceuticals to Participate in Three Investor Conferences This Month”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-410394","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nInfinity Pharmaceuticals to Participate in Three Investor Conferences This Month - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Infinity Pharmaceuticals to Participate in Three Investor Conferences This Month - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Infinity Pharmaceuticals to Participate in Three Investor Conferences This Month CAMBRIDGE, Mass.–(BUSINESS WIRE)–Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that CEO Adelene Perkins is scheduled to present virtually at three investor conferences this month. The Infinity leadership team also will be available for one-on-one meetings during the investor conferences on January 7-8 and 11-14, 2021. Details for all three investor conferences are as follows: 39th Annual J.P. Morgan Healthcare Conference – Corporate Presentation Date: January 14, 2021 Time: 2:00 p.m. ET Webcast: Audio-only Link to Webcast Here 2021 LifeSci Advisors – Corporate Access Event Date: January 7-13, 2021 Time: Management available for 1×1 meetings H.C. Wainwright BioConnect 2021 Conference – Corporate Presentation Date: January 11-14, 2021 The session time is … Continue reading "Infinity Pharmaceuticals to Participate in Three Investor Conferences This Month"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-07T13:38:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210107005217r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Infinity Pharmaceuticals to Participate in Three Investor Conferences This Month\",\"datePublished\":\"2021-01-07T13:38:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\\\/\"},\"wordCount\":402,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210107005217r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\\\/\",\"name\":\"Infinity Pharmaceuticals to Participate in Three Investor Conferences This Month - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210107005217r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-01-07T13:38:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210107005217r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210107005217r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infinity Pharmaceuticals to Participate in Three Investor Conferences This Month\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Infinity Pharmaceuticals to Participate in Three Investor Conferences This Month - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\/","og_locale":"en_US","og_type":"article","og_title":"Infinity Pharmaceuticals to Participate in Three Investor Conferences This Month - Market Newsdesk","og_description":"Infinity Pharmaceuticals to Participate in Three Investor Conferences This Month CAMBRIDGE, Mass.–(BUSINESS WIRE)–Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that CEO Adelene Perkins is scheduled to present virtually at three investor conferences this month. The Infinity leadership team also will be available for one-on-one meetings during the investor conferences on January 7-8 and 11-14, 2021. Details for all three investor conferences are as follows: 39th Annual J.P. Morgan Healthcare Conference – Corporate Presentation Date: January 14, 2021 Time: 2:00 p.m. ET Webcast: Audio-only Link to Webcast Here 2021 LifeSci Advisors – Corporate Access Event Date: January 7-13, 2021 Time: Management available for 1×1 meetings H.C. Wainwright BioConnect 2021 Conference – Corporate Presentation Date: January 11-14, 2021 The session time is … Continue reading \"Infinity Pharmaceuticals to Participate in Three Investor Conferences This Month\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-07T13:38:41+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210107005217r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Infinity Pharmaceuticals to Participate in Three Investor Conferences This Month","datePublished":"2021-01-07T13:38:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\/"},"wordCount":402,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210107005217r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\/","name":"Infinity Pharmaceuticals to Participate in Three Investor Conferences This Month - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210107005217r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-01-07T13:38:41+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210107005217r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210107005217r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-pharmaceuticals-to-participate-in-three-investor-conferences-this-month\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Infinity Pharmaceuticals to Participate in Three Investor Conferences This Month"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/410394","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=410394"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/410394\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=410394"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=410394"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=410394"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}